Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models (Q39837427)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models |
scientific article |
Statements
1 reference
Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models (English)
1 reference
Gongjie Liu
1 reference
Stacey A Taylor
1 reference
Cindy H Marrinan
1 reference
Yunsheng Hsieh
1 reference
W Robert Bishop
1 reference
Paul Kirschmeier
1 reference
Brian J Long
1 reference
1 December 2009
1 reference
1 reference
125
1 reference
11
1 reference
2711-2720
1 reference
Identifiers
1 reference
1 reference